Or call
(888) 352-RUSH for help arranging an appointment.
Specialty:
Pediatric Cardiology
Interventional Cardiology
Board Certification:
Faculty Rank: Professor
Medical or Graduate Education:
University of Jordan Medical School
Residency:
Yale University School of Medicine - Pediatrics
Fellowship:
Yale University School of Medicine - Pediatric Cardiology
Clinical Expertise:
Adult congenital heart disease
Angioplasty
Hybrid interventional therapies, including VSD and HLHS management
Interventional cardiology for congenital and structural heart disease
Percutaneous valve replacement and repair (aortic, mitral and pulmonic)
Septal defect closure
Stent placement
Valvular heart disease
Valvuloplasty
Ventricular septal defect closure
Research Interests:
Balloon-expandable stents
Nonsurgical approaches to treatment of congenital heart disease
Percutaneous pulmonary valve replacement
Structural heart disease intervention
Transcatheter aortic valve replacement
Transcatheter mitral valve repair with mitra clip
Languages Spoken:
Rush Center for Congenital & Structural Heart Disease 1650 W. Harrison St. 708 Kellogg Chicago, IL 60612 Phone: (312) 942-6800Fax: (312) 942-6801View Larger Map • Driving Directions
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
State-of-the-art percutaneous pulmonary valve therapy. Medium and Long-Term Outcomes After Bilateral Pulmonary Artery Stenting in Children and Adults With Congenital Heart Disease. Innovative resource utilization to fashion individualized covered stents in the setting of aortic coarctation. Percutaneous Implantation of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position: Early Phase 1 Results From an International Multicenter Clinical Trial. Fenestration of a Gore Helex Septal Occluder device in a patient with diastolic dysfunction of the left ventricle Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association. Approaching the aortic valve: still some legwork to do! Pediatric catheterization laboratory anticoagulation with bivalirudin Pulmonary perfusion scans following transcatheter patent ductus arteriosus closure using the Amplatzer devices Device closure of secundum atrial septal defects: To balloon size or not to balloon size. Transcatheter approaches to non-valvar structural heart disease Bailout perventricular pulmonary valve implantation following failed percutaneous attempt using the Edwards Sapien transcatheter heart valve Comparison of Surgical, Stent, and Balloon Angioplasty Treatment of Native Coarctation of the Aorta An Observational Study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). Tips and tricks to prevent prolapse of the amplatzer septal occluder through Large atrial septal defects. Transcatheter tricuspid valve replacement with the Edwards SAPIEN valve. Medium-term outcomes for peripheral pulmonary artery stenting in adults with congenital heart disease. Pediatric catheterization laboratory anticoagulation with bivalirudin. Pulmonary perfusion scans following transcatheter patent ductus arteriosus closure using the Amplatzer devices. Coarctation of the aorta: From fetal life to adulthood. [Transcatheter implantation of Edwards-SAPIEN THV valve in pulmonary position]. Percutaneous device closure of congenital and iatrogenic ventricular septal defects in adult patients Interventional fellowship in structural and congenital heart disease for adults SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the Past and Standards for the Future Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease The SCAI Structural Heart Disease Council: toward addressing training, credentialing, and guidelines for structural heart disease intervention Interventional fellowship in structural and congenital heart disease for adults SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings: assessments of the past and standards for the future Perventricular device closure of congenital muscular ventricular septal defects Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: risk factors and recommendations The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects Intracardiac echocardiography for the guidance of percutaneous procedures Pediatric hybrid interventions: one family's story The use of intracardiac echocardiography and other intracardiac imaging tools to guide noncoronary cardiac interventions Feasibility of real-time three-dimensional transoesophageal echocardiography for guidance of percutaneous atrial septal defect closure Intracardiac echocardiography during interventional and electrophysiological cardiac catheterization Transcatheter closure of secundum atrial septal defect in the elderly Percutaneous closure of perimembranous ventricular septal defect with an Amplatzer Duct Occluder in a dextrocardia patient Percutaneous pulmonic valve implantation Use of real time three-dimensional transesophageal echocardiography in intracardiac catheter based interventions The off-versus on-label use of medical devices in interventional cardiovascular medicine?: Clarifying the ambiguity between regulatory labeling and clinical decision making, part III: structural heart disease interventions A new device to close secundum atrial septal defects: first clinical use to close multiple defects in a child Hybrid therapy for hypoplastic left heart syndrome: reality check Pathophysiology of congenital heart disease in the adult, part II. Simple obstructive lesions Pathophysiology of congenital heart disease in the adult: part III: Complex congenital heart disease PFO closure complications from the AGA registry Closure of muscular ventricular septal defects: Transcatheter and hybrid techniques The Amplatzer Septal Occluder, a transcatheter device for atrial septal defect closure Perventricular closure of muscular ventricular septal defects: How do I do it? Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions Percutaneous closure of left ventricular pseudoaneurysms after Ross procedure ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease) ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease) ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Seconds-Count.org offers enhanced tools for patients and physicians Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism Pediatric cardiac interventions Transcatheter device closure of atrial septal defects in patients older than 60 years of age: immediate and follow-up results
To watch a brief video of Ziyad M. Hijazi, MD, MPH, click the play button at the lower left corner of the video frame below. (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
View Transcript Every time I wake up in the morning, I look forward to come to the hospital to work because I know that that day I will make the difference in somebody’s life. Most of our patients, when they come to us, they have a lot of symptoms. If it’s children, they can’t exercise. They can’t do anything. And if you do something for their heart and you make it better, these children grow, and then when they come back for follow-up, they’re jumping and laughing. And you become really a good friend, not just to the child, but also to the family of these children. And you become a member of their family.
In adult patients with valve disease, an eighty, eighty-five-year-old patient, they are limited. They can’t exercise. You insert a new valve, or you repair a leaky valve in them. They come back after a month or six months with a big smile on their face, their symptoms are gone, and they are doing much better. So the innovations and the technology that we have, that’s what led to the help of these patients. So I always look forward to what’s the new technology out there — devices, valves — to bring so that we can benefit all our patients.
;){kind=link}
;){kind=link}
;){kind=link}
;){kind=link}